{"id":617329,"date":"2023-03-11T17:40:21","date_gmt":"2023-03-11T23:40:21","guid":{"rendered":"https:\/\/news.sellorbuyhomefast.com\/index.php\/2023\/03\/11\/study-finds-prostate-cancer-treatment-can-wait-for-most-men\/"},"modified":"2023-03-11T17:40:21","modified_gmt":"2023-03-11T23:40:21","slug":"study-finds-prostate-cancer-treatment-can-wait-for-most-men","status":"publish","type":"post","link":"https:\/\/newsycanuse.com\/index.php\/2023\/03\/11\/study-finds-prostate-cancer-treatment-can-wait-for-most-men\/","title":{"rendered":"Study finds prostate cancer treatment can wait for most men"},"content":{"rendered":"
\n

Researchers have found long-term evidence that actively monitoring localized prostate cancer is a safe alternative to immediate surgery or radiation.<\/p>\n

The results, released Saturday, are encouraging for men who want to avoid treatment-related sexual and incontinence problems, said Dr. Stacy Loeb, a prostate cancer specialist at NYU Langone Health who was not involved in the research.<\/p>\n

The study directly compared the three approaches \u2014 surgery to remove tumors, radiation treatment and monitoring. Most prostate cancer grows slowly, so it takes many years to look at the disease\u2019s outcomes.<\/p>\n

\u201cThere was no difference in prostate cancer mortality at 15 years between the groups,\u201d Loeb said. And prostate cancer survival for all three groups was high \u2014 97% regardless of treatment approach. \u201cThat\u2019s also very good news.\u201d<\/p>\n

The results were published Saturday in the New England Journal of Medicine and presented at a European Association of Urology conference in Milan, Italy. Britain\u2019s National Institute for Health and Care Research paid for the research.<\/p>\n

\"This<\/picture>
This 1974 microscope image made available by the Centers for Disease Control and Prevention shows changes in cells indicative of adenocarcinoma of the prostate.<\/span>Dr. Edwin P. Ewing Jr. \/ CDC via AP, file<\/span><\/figcaption><\/figure>\n

Men diagnosed with localized prostate cancer shouldn\u2019t panic or rush treatment decisions, said lead author Dr. Freddie Hamdy of the University of Oxford. Instead, they should \u201cconsider carefully the possible benefits and harms caused by the treatment options.\u201d<\/p>\n

A small number of men with high-risk or more advanced disease<\/a> do need urgent treatments, he added.<\/p>\n

Researchers followed more than 1,600 U.K. men who agreed to be randomly assigned to get surgery, radiation or active monitoring. The patients\u2019 cancer was confined to the prostate, a walnut-sized gland that\u2019s part of the reproductive system. Men in the monitoring group had regular blood tests and some went on to have surgery or radiation.<\/p>\n

Death from prostate cancer occurred in 3.1% of the active-monitoring group, 2.2% in the surgery group, and 2.9% in the radiation group, differences considered statistically insignificant.<\/p>\n

At 15 years, cancer had spread in 9.4% of the active-monitoring group, 4.7% of the surgery group and 5% of the radiation group. The study was started in 1999, and experts said today\u2019s monitoring practices are better, with MRI imaging and gene tests guiding decisions.<\/p>\n

\u201cWe have more ways now to help catch that the disease is progressing before it spreads,\u201d Loeb said. In the U.S., about 60% of low-risk patients choose monitoring, now called active surveillance.<\/p>\n

Hamdy said the researchers had seen the difference in cancer spread at 10 years and expected it to make a difference in survival at 15 years, \u201cbut it did not.\u201d He said spread alone doesn\u2019t predict prostate cancer death.<\/p>\n

\u201cThis is a new and interesting finding, useful for men when they make decisions about treatments,\u201d he said.<\/p>\n<\/div>\n

Read More<\/a>
\n The Associated Press<\/p>\n","protected":false},"excerpt":{"rendered":"

Researchers have found long-term evidence that actively monitoring localized prostate cancer is a safe alternative to immediate surgery or radiation. The results, released Saturday, are encouraging for men who want to avoid treatment-related sexual and incontinence problems, said Dr. Stacy Loeb, a prostate cancer specialist at NYU Langone Health who was not involved in the […]<\/p>\n","protected":false},"author":1,"featured_media":617330,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[534,2915,3437],"tags":[],"class_list":{"0":"post-617329","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-financial","8":"category-finds","9":"category-study"},"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/newsycanuse.com\/index.php\/wp-json\/wp\/v2\/posts\/617329","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/newsycanuse.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/newsycanuse.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/newsycanuse.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/newsycanuse.com\/index.php\/wp-json\/wp\/v2\/comments?post=617329"}],"version-history":[{"count":0,"href":"https:\/\/newsycanuse.com\/index.php\/wp-json\/wp\/v2\/posts\/617329\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/newsycanuse.com\/index.php\/wp-json\/wp\/v2\/media\/617330"}],"wp:attachment":[{"href":"https:\/\/newsycanuse.com\/index.php\/wp-json\/wp\/v2\/media?parent=617329"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/newsycanuse.com\/index.php\/wp-json\/wp\/v2\/categories?post=617329"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/newsycanuse.com\/index.php\/wp-json\/wp\/v2\/tags?post=617329"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}